Compared to earlier research, our study expanded the scope of analysis by incorporating additional variables, such as AMH and androstenedione levels, specific IVF-ET treatment protocols (e.g., embryo cryopreservation), controlled ovarian stimulation strategies for fresh embryo transfer, endometrial preparation methods for frozen embryo transfer, and comorbid conditions like prepregnancy diabetes and hypertension. The gene discussed is AMH; the disease is hypertensive disorder.